Jan Desmyter - Publications, H-index & Citations

Jan Desmyter

机构信息待补充

59H指数

347论文数

1.3W被引数

收录论文 20

发表时间

Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype

AIDS

IF3.1

2001-03-01

OAAI

Van Laethem, K; Witvrouw, M; Pannecouque, C; Van Remoortel, B; Schmit, JC; Esnouf, R; Kleim, JP; Balzarini, J; Desmyter, J; De Clercq, E; Vandamme, AM

Recent increase in diagnoses of HIV infections based on surveillance system data in Belgium

AIDS

IF3.1

2000-12-01

OAAI

Sasse, A; Liesnard, C; van der Groen, G; Burtonboy, G; Plum, J; Sondag-Thull, D; Sprecher, S; Van Ranst, M; Zissis, G; Desmyter, J

Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2000-08-01

OAAI

Van Vaerenbergh, K; Van Laethem, K; Albert, J; Boucher, CAB; Clotet, B; Floridia, M; Gerstoft, J; Hejdeman, B; Nielsen, C; Pannecouque, C; Perrin, L; Pirillo, MF; Ruiz, L; Schmit, JC; Schneider, F; Schoolmeester, A; Schuurman, R; Stellbrink, HJ; Stuyver, L; Van Lunzen, J; Van Remoortel, B; Van Wijngaerden, E; Vella, S; Witvrouw, M; Yerly, S; De Clercq, E; Desmyter, J; Vandamme, AM

Tempo and mode of human and simian T-lymphotropic Virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences

MOLECULAR BIOLOGY AND EVOLUTION

IF5.3

2000-03-01

OAAI

Salemi, M; Desmyter, J; Vandamme, AM

High prevalence of GB virus C/hepatitis G virus in Kinshasa, Democratic Republic of Congo: A phylogenetic analysis

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2000-02-01

PREAI

Liu, HF; Muyembe-Tamfum, JJ; Dahan, K; Desmyter, J; Goubau, P

Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV 非核苷类逆转录酶抑制剂对HIV-2和SIV的活性

AIDS

IF3.1

1999-08-01

OAAI

Witvrouw, M; Pannecouque, C; Van Laethem, K; Desmyter, J; De Clercq, E; Vandamme, AM

The discovery of two new divergent STLVs has implications for the evolution and epidemiology of HTLVs

REVIEWS IN MEDICAL VIROLOGY

IF6.6

1999-07-01

PREAI

Van Brussel, M; Salemi, M; Liu, HF; Goubau, P; Desmyter, J; Vandamme, AM

Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries

AIDS

IF3.1

1998-10-01

OAAI

Schmit, JC; Van Laethem, K; Ruiz, L; Hermans, P; Sprecher, S; Sonnerborg, A; Leal, M; Harrer, T; Clotet, B; Arendt, V; Lissen, E; Witvrouw, M; Desmyter, J; De Clercq, E; Vandamme, AM

African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies

JOURNAL OF VIROLOGY

IF3.8

1998-05-01

OAAI

Vandamme, AM; Salemi, M; Van Brussel, M; Liu, HF; Van Laethem, K; Van Ranst, M; Michels, L; Desmyter, J; Goubau, P

1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives:: A new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

1998-03-01

OAAI

Witvrouw, M; Arranz, ME; Pannecouque, C; Declercq, R; Jonckheere, H; Schmit, JC; Vandamme, AM; Diaz, JA; Ingate, ST; Desmyter, J; Esnouf, R; Van Meervelt, L; Vega, S; Balzarini, J; De Clercq, E

Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)

MOLECULAR PHARMACOLOGY

IF3

1998-02-01

120

PREAI

Esté, JA; Cabrera, C; Schols, D; Cherepanov, P; Gutierrez, A; Witvrouw, M; Pannecouque, C; Debyser, Z; Rando, RF; Clotet, B; Desmyter, J; De Clercq, E

Post-exposure prophylaxis after accidental prion inoculation

LANCET

IF88.5

1998-02-01

PREAI

Van Ranst, M; Desmyter, J

Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein

MOLECULAR PHARMACOLOGY

IF3

1997-07-01

PREAI

Este, JA; Schols, D; DeVreese, K; VanLaethem, K; Vandamme, AM; Desmyter, J; DeClercq, E

SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

1997-02-01

OAAI

Witvrouw, M; Balzarini, J; Pannecouque, C; JhaumeerLaulloo, S; Este, JA; Schols, D; Cherepanov, P; Schmit, JC; Debyser, Z; Vandamme, AM; Desmyter, J; Ramadas, SR; De Clercq, E

Prevalence of hepatitis A, B and C in the Flemish population

EUROPEAN JOURNAL OF EPIDEMIOLOGY

IF5.9

1997-01-01

PREAI

Beutels, M; VanDamme, P; Aelvoet, W; Desmyter, J; Dondeyne, F; Goilav, C; Mak, R; Muylle, L; Pierard, D; Stroobant, A; VanLoock, F; Waumans, P; Vranckx, R

The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports an African origin for the human T-lymphotropic simian T-lymphotropic group of viruses

JOURNAL OF GENERAL VIROLOGY

IF4.3

1996-05-01

OAAI

Vandamme, AM; Liu, HF; VanBrussel, M; DeMeurichy, W; Desmyter, J; Goubau, P

The genomic structure of a new simian T-lymphotropic virus, STLV-PH969, differs from that of human T-lymphotropic virus types I and II

JOURNAL OF GENERAL VIROLOGY

IF4.3

1996-02-01

OAAI

VanBrussel, M; Goubau, P; Rousseau, R; Desmyter, J; Vandamme, AM